We noted a high level expression of RRM2, MYBL2, and some other genes such as GALNT14, CENPU, ACOXL, and U2 at 0 weeks during active phase of infection, which were downregulated at 8 weeks after therapy (Table 1). Here, RRM2 is linked to infection.